mdv3100
Showing 1 - 9 of 9
Prostate Cancer, Hormone Refractory Prostate Cancer Trial in United States (MDV3100)
Completed
- Prostate Cancer
- Hormone Refractory Prostate Cancer
- MDV3100
-
Boston, Massachusetts
- +8 more
Sep 10, 2019
Prostate Cancer, Prostate Tumors, Castration Resistant Prostate Cancer (CRPC) Trial in Japan (MDV3100)
Completed
- Prostate Cancer
- +2 more
- MDV3100
-
Chubu, Japan
- +6 more
Nov 9, 2018
Pharmacokinetics of MDV3100, Castration Resistant Prostate Cancer (CRPC) Trial in George, Port Elizabeth (MDV3100, Pioglitazone,
Completed
- Pharmacokinetics of MDV3100
- Castration Resistant Prostate Cancer (CRPC)
- MDV3100
- +4 more
-
George, South Africa
- +1 more
Jun 22, 2017
Metastatic Castration-Resistant Prostate Cancer Trial (MDV3100)
Approved for marketing
- Metastatic Castration-Resistant Prostate Cancer
- MDV3100
- (no location specified)
Feb 15, 2017
Pharmacokinetics of MDV3100, Healthy Subjects, Kidney Diseases Trial in Chisinau (MDV3100)
Completed
- Pharmacokinetics of MDV3100
- +2 more
- MDV3100
-
Chisinau, Moldova, Republic ofArensia
Sep 12, 2014
Healthy Subjects, Pharmacokinetics of MDV3100 Trial in Zuidlaren (MDV3100)
Completed
- Healthy Subjects
- Pharmacokinetics of MDV3100
- MDV3100
-
Zuidlaren, NetherlandsPRA International
Jul 26, 2013
Healthy Subjects, Pharmacokinetics, Drug-Drug Interaction Trial in Paris (MDV3100, Gemfibrozil, Itraconazole)
Completed
- Healthy Subjects
- +2 more
- MDV3100
- +2 more
-
Paris, FranceSGS
Jul 30, 2013
Healthy Subjects, Castration Resistant Prostate Cancer (CRPC), Relative Bioavailability Trial in Berlin (MDV3100)
Completed
- Healthy Subjects
- +3 more
- MDV3100
-
Berlin, GermanyParexel International GmbH
Jul 26, 2013